Just the facts

Just the facts

There has been a great deal of noise surrounding the insulin space, so we thought we’d bring those pesky facts into the arena. Here are the numbers from the three largest insulin companies for 2021


Humalog $2453 Billion
Humulin $1222.6 Billion
Basaglar $892.5 Million

Novo Nordisk

Long Acting $2648.37 Billion
Pre-Mix $1642.48 Billion
Fast Acting $2593.10 Billion


Lantus $2721.45 Billion
Toujeo $1057.37 Billion

Add it all . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.